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Bovine viral diarrhea virus (BVDV) infection of bovine fetuses in the first 125 days of pregnancy 
results in persistently infected (PI) cattle and transiently infected (TI) cattle become infected, but have a 
developed immune system enabling them to clear the virus.  PI cattle are the main source of BVDV 
infection in populations causing significant economic losses to the industry worldwide.  The mechanisms 
that lead to this “immunotolerant” state are not well defined.  Following maternal inoculation with 
BVDV on day 75 of gestation, fetal infection was determined by presence of viral mRNA.  Fetal infection 
occurred by day 89 of gestation with a peak at day 97 and a significant 10-fold decrease in viral titer at 
days 192 and 245 of gestation.  BVDV was never completely eliminated in the fetus and persisted at 
lower, but significant levels.  We hypothesized that there is dysgenesis of the fetal thymus, inhibiting 
functional innate and adaptive immune responses following maternal infection with BVDV.  Total RNA 
was extracted from the thymus of uninfected control and BVDV-infected fetuses at days 89, 97, 190, and 
245 of gestation.  Genes representing the innate immune system, T and B cell receptor signaling, and 
the antigen processing and presentation in both the MHC I and MHC II pathways were explored using 
RT-qPCR.  There were significant increases (P ≤ 0.05) observed in all innate genes analyzed (RIG-I, IRF7, 
NF-kB, IFNβ, and ISG15) in TI fetuses, with minimal responses in PI fetuses.  There were significant 
decreases (P ≤ 0.05) of antigen presentation genes and adaptive immune system genes LMP2, TAP1, 
β2M, CD8a, CD8b, CIITA, CD4, IFI16, CXCL16, CXCR6, and CD79b in day 190 PI fetuses.  Persistent BVDV 
infection may initiate fetal adaptive immune responses, which are not fully activated over time because 
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of “immunotolerance” caused by impaired antigen processing.  Longer-term consequences of fetal PI 
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Bovine viral diarrhea virus (BVDV) is a small (12.5 kb genome) enveloped RNA virus included in 
the genus Pestivirus and Family Flaviviridae.  It was first discovered in the 1940s and is an infectious 
agent that affects herd productivity and reproduction of cattle worldwide (Childs 1946).  BVDV causes 
significant economic losses through increased morbidity and mortality, due to immunosuppression 
decreasing performance in cattle herds and costing the industry millions of dollars each year.  This 
industry loss is inflated when proper control methods are not maintained, allowing for infected calves to 
continue spread of the virus (Pinior et al., 2017, Richter et al., 2017).  In the United States, control 
standards include the identification and elimination of persistently infected animals, preventing entry of 
persistently infected animals to the herd using diagnostic testing, and vaccination of animals (Fulton et 
al., 2006, Van Campen 2010).  The more recent vaccines that have been developed reduce the risk of 
fetal infection, but their efficacy is increased when the vaccine strain matches the strain to which the 
herd may have contact (Newcomer et al., 2015).  The type of vaccine and time that it was given can also 
have an effect.  If a modified-live vaccine is given to a pregnant dam, the fetus would develop a 
persistent infection (Palomares et al., 2013).  Vaccination also interferes with BVDV diagnostic testing in 
which cattle vaccinated against BVDV can have a false positive result when using a diagnostic technique 
that tests for antibodies.  This false positive may prevent the selling and moving of animals to other 
locations.  Financial losses due to BVDV ranged from 50 – 687.80 USD per animal worldwide, but 
regardless of the size of the herd, losses peak one year after the virus is introduced in the herd, when 
reproductive failures and decreased productivity are observed (Damman et al., 2015, Richter et al., 
2017).  A better understanding of mechanisms that lead to the establishment of persistent BVDV 
infection may aid in disruption of the transmission cycle.    
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HISTORY    
  BVDV was first described in 1946 after a disease of unknown origin, “X”, spread through a 
Canadian dairy herd as both acute and subacute forms (Childs 1946).  Within this herd, young cattle that 
became infected had a sudden onset of illness with death following 7 to 10 days later.  The more severe 
type of the disease led to death in mature naïve cattle within 3 to 4 days with clinical signs including 
pyrexia, tachypnea, tachycardia, anorexia, dehydration, and diarrhea, with some cattle exhibiting 
ulcerative lesions on mucosal tissues (Childs 1946).  Post-mortem findings unveiled extensive loss of 
gastrointestinal epithelium, with erosive lesions observed from the nares to esophagus and throughout 
the upper and lower alimentary system.  Hemorrhage in the kidneys was also reported as well as with 
petechiation in the ureters and bladder and possible thrombosis within the spleen (Childs 1946).  In the 
same year, Cornell University, also reported an outbreak of gastroenteritis and severe diarrhea, along 
with pyrexia, tachypnea, and ulcers present in the mouth, nares, and muzzle in cattle (Olafson et al., 
1946).  The post-mortem findings from this herd were consistent with those described for “X” disease 
and the disease became known as virus diarrhea (VD) of cattle (Childs 1946, Olafson P et al., 1946).   
In the 1950s, Iowa farmers reported a disease in cattle with clinical signs consisting of 
mucopurulent nasal discharge with gross erosions and hemorrhages of the intestinal tract which they 
termed mucosal disease (MD) (Ramsey et al., 1951).  BVDV consisting of two genotypes, 1 and 2,  and 
two biotypes, cytopathic (cp) and noncytopathic (ncp) (Goens 2002).  The cp biotype was named in 
reference to its lytic behaviors in in vitro cell cultures (Gillespie et al., 1961).  The majority of worldwide 
economic losses that occur are connected to the ncpBVDV type and its ability to cause persistent 
infection (PI), which is how the virus continues to spread throughout herds (Bissey et al., 1991, 




TRANSMISSION AND PATHOGENESIS OF TRANSPLACENTAL INFECTION 
BVDV is transmitted either directly from infected animals through excretions or secretions 
including nasal discharge, tears, saliva, urine, feces, milk, and semen, or indirectly through fomites such 
as equipment (i.e. halters or nose tongs).  It can survive up to 3 weeks in the environment (Khodakaram-
Tafti et al., 2017).  BVDV is also able to transmit vertically from dam to fetus at any age of gestation.  
Cows have an epitheliochorial (cotyledonary) placenta which consists of three fetal layers (fetal 
endothelial cells, fetal connective tissue, and chorionic epithelial cells) and three maternal layers 
(endometrial epithelial cells, maternal connective tissue, and maternal endothelial cells).  This type of 
placenta inhibits large maternal immunoglobulins (IgG, IgM) from crossing the placenta to protect the 
fetus.  BVDV has a high predilection for the walls of blood vessels, in particular the smooth muscle cells 
in the tunica media as well as epithelial tissues including the reproductive, central nervous system, and 
lymphoid tissues, therefore, BVDV can be detected in intercotyledonary fetal membranes and 
placentomes of the placenta (Ohmann 1983, Booth et al., 1995, Fredriksen et al., 1999a, Fredriksen et 
al., 1999b).  Additionally, transplacental-BVDV infection affects multiple organs and causes lesions that 
may appear in the fetal lymphatic, digestive, pulmonary, urogenital, nervous, and reproductive systems 
(Shin et al., 2001, Bolin 2002).  The Peyer’s patches, of the fetal digestive system, have been reported to 
have the highest amount of virus (Yasuda et al., 2006).  The main route of infection is caused by the 
presence of persistently infected cattle in the herd that infect naïve cattle (Grooms 2004).   
Naïve heifers infected prior to conception through day 45 of gestation, have a decreased 
conception rate and there is an increase in early embryonic deaths (Houe et al., 1993).  Infection of a 
naïve pregnant cow between days 45 to 175 of gestation can cause congenital defects, abortions, or 
more commonly, if the fetus survives, it may become persistently infected (PI) and continuously shed 
virus throughout its life.  Congenital defects range from hydrocephalus, hydranencephaly, porencephaly, 
microencephaly, or cerebellar hypertrophy with cerebellar hypertrophy being the most common 
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(Agerholm et al., 2015).  These central nervous system defects mainly occur through direct damage to 
the cells or the inflammatory responses that occur due to the fetus’s response to the virus (Agerholm et 
al., 2015).  While the mechanisms of fetal infection are unclear, there is evidence that a vasculitis on the 
maternal side of placentation may be the main source of virus to be passed to the fetus via circulation 
(McClurkin et al., 1984, Murray 1991, Fredriksen et al., 1999a).  BVDV has also been identified in 
binuclear trophoblast cells of the fetus (Fredriksen et al., 1999a).  Normally, fetuses that are infected 
between days 18 and 125 of gestation with the ncpBVDV biotype can become a PI and therefore 
immunotolerant to the virus (McClurkin et al., 1984, Virakul et al., 1988).  Calves born apparently normal 
yet persistently infected, when bred, are able to produce persistently infected calves (McClurkin et al., 
1984).   
A persistent infection occurs prior to 120 days of gestation in which a competent immune 
system has not developed and the fetus is able to shed virus throughout its lifetime (Brownlie et al., 
1987, Lanyon et al., 2014).  When infection occurs later in gestation, greater than 135 days of gestation, 
the fetus may also end up with congenital defects or they can become persistently or transiently 
infected.  A transient, or acute, infection occurs after the immune system is more established after day 
120 of gestation, in which the fetus can mount an effective immune response and successfully clear the 
virus with no lingering side-effects (Casaro et al., 1971, Chase et al., 2004).   
  BVDV persistently infected animals can also act as a synergistic agent for various infections due 
to the immunosuppression caused by the virus (Bolin 2002, Fulton 2013).  These synergistic infections 
can be of respiratory, enteric, or reproductive infections.  Bovine herpesvirus 1 (BHV-1), bovine 
respiratory syncytial virus (BRSV), parainfluenza virus 3 (PI-3V), and bovine coronavirus are viral 
infections that have been isolated in BVDV infected animals (Bolin 2002, Fulton 2013).  Less is known 
about mixed infections with BVDV causing enteric disease, but BVDV as well as BRSV has led to more 
pronounced rotavirus, Salmonella spp., Escherichia coli, or cryptosporidiosis infections (Bolin 2002, 
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Fulton 2013).  Reproductive disease is more common than enteric disease especially because abortions 
make it relatively easy to identify.  BVDV has been linked with numerous mixed infections and a variety 
of agents which include Leptospira borgpetersenii serovar hardjo, Coxiella burnetti, Campylobacter fetus, 
Arcanobacterium pyogenes, Bacillus spp., or Neospora caninumm (Bolin 2002, Fulton 2013).  For all 
diseases related to the different organ systems, the severity of a secondary infection typically has more 
severe clinical signs in BVDV PI calves, than healthy calves.   
BVDV AND IMMUNITY  
Persistently infected cattle are immunotolerant to BVDV and are unable to clear the virus.  The 
inability of the host to clear the virus may be because of either a ‘hit-and-run’ method, which generates 
transiently infected animals or an ‘infect-and-persist’ method which generates PI animals (Rhodes et al., 
1999, Endsley et al., 2003, Peterhans et al., 2003b, Grooms 2004).  The ‘hit-and-run’ method is the 
explanation for how acute infection moves through a herd, in which animals become infected and 
transfers the disease to a second animal before the initially infected animal clears it, whereas the ‘infect-
and-persist’ is how the disease achieves persistence within a herd.  This is the same or similar method 
that HIV and herpes infection are associated within their hosts (Peterhans et al., 2003a, Schweizer et al., 
2006).  It is currently thought that fetuses become PI because of an impaired innate immune response 
coupled with evasion of the adaptive immune system, thus the ‘infect and persist’ (Peterhans et al., 
2013). 
In a previous study, at Colorado State University, naïve heifers were inoculated with BVDV and 
viral blood titers were measured in the dam and fetus at various time points throughout gestation 
(Smirnova et al., 2008, Smirnova et al., 2012).  Naïve pregnant heifers were inoculated with BVDV at day 








Figure 1. Viremia (BVDV RNA expression; 2-∆Ct) following infection with ncpBVDV on day 75 in heifers and 






day 89 indicating a rapid immune response resulting in clearance of the virus within 2 weeks of infection 
(Smirnova et al., 2012).  Fourteen days after inoculation of the heifer, BVDV was present in the fetus as 
seen in the viral titers.  At this 2 week presence of BVDV in the fetus (day 97 of gestation), the viral load 
peaks and a significant decrease, but not clearance, of BVDV RNA is observed on days 192 and 245.  It is 
important to note that even with the significant decrease of viral titer at days 192 and 245, there is still 
significant titer at these days.  This decrease may be indicative of partial clearance of the virus, which 
supports the idea that during the early stages of the infection, a slight fetal immune response occurs, 
however, there is a lack of complete clearance of the virus (Smirnova et al., 2012).  The inability of the 
fetus to completely clear the virus may indicate a dysfunctional immune system, given the fact that no 
antibodies are present to clear or seroconvert these underdeveloped immune systems.   
INNATE IMMUNITY   
The innate immune system is the first line of natural defense against foreign pathogens and is 
mediated by pattern recognition receptors (PRR).  Cellular toll-like receptors (TLRs) and RIG-I-like 
receptors (RLRs) are on the endosome membrane of a variety of cells including phagocytes and 
epithelial cells (Saito et al., 2007, Blasius et al., 2010, Loo et al., 2011).  RLRs include RIG-I (retinoic acid-
inducible gene I), MDA5 (melanoma differentiation associated factor 5), and LGP2 (laboratory of 
genetics and physiology).  These receptors, as well as others, recognize viral nucleic acids, such as 
pathogen-associated molecular patterns (PAMPs), in order to initiate an innate immune response 
(Figure 2).  Once the receptors recognize a viral infection, downstream signal transduction is activated 
with the phosphorylation of transcription factors and upregulation of interferon (IFN) type 1 
transcription, which then induces intracellular immune responses and elicit antiviral processes 
(Alexopoulou et al., 2001, Samuel 2001, Loo and Gale 2011).  These receptors are able to trigger the 
innate defenses of myeloid cells, epithelial cells, and cells of the central nervous system which initiate 
production of IFNs (Loo and Gale 2011). 
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Another division of innate immunity is the complement system that opsonizes and destroys 
pathogens based on the PAMP recognition mechanism, where the PAMPs interact with the PRR domain 
of the TLR (Liszewski et al., 2013).  In addition to extracellular recognition, PAMPs can also be detected 
intracellularly, which is critical for recognizing intracellular viruses such as BVDV (Mogensen 2009, 
Blasius and Beutler 2010, Takeuchi et al., 2010).  In vivo studies of BVDV in infected fetuses showed an 
upregulation of viral recognition receptors, RIG-I and MDA5 helicases.  Additionally, interferon 
stimulated genes (ISGs) were also found to be upregulated in fetal blood, fetal splenic tissue as well as in 
PI post-natal steer blood.  The in vivo increase in ISGs are indicative of a type I IFN response.  ISGs can 
also have positive feedback effects, increasing type I FIN transcription until the infection is cleared 
(Charleston et al., 2002, Smirnova et al., 2008, Shoemaker et al., 2009).  However, in vitro studies 
showed an opposite effect in which ISGs and type I IFN production were inhibited (Baigent et al., 2002).  
Viral recognition receptors signal IFN production through IRF3 or IRF7.  IRF3 and IRF7 are 
phosphorylated in the cytoplasm by TBK1 or IKKε, then translocate into the nucleus where they induce 
transcription of IFNs (Shen et al., 2014).  One of the reasons for the persistence of BVDV was a failed 
activation of IRF3 and IRF7, thus a lack of ISG production interferon response (Baigent et al., 2002).  In 
addition to IRF3 and IRF7, production of IFNs can also be induced and regulated through the nuclear 
factor kappa B (NF-kB) transcription factor (Pfeffer 2011).  There are five members in the NF-kB family 
and like IRF3 and -7, the NF-kB pathway is activated by TLRs, RLRs, and nucleotide-binding 
oligomerization domain (NOD)-like receptors (NLRs) (Dev et al., 2010).  However, upon repeated 
exposure to an insult, a reduced response is observed.  This is directly caused by NF-kB in which excess 
dimerization of NF-kB occurs which bind to transcriptional targets causing the attenuation of signaling 
cascades or the receptors, and are not as sensitive to this repeated challenge (Dev et al., 2010).  This 
attenuation or decreased receptor sensitivity may be important for the tolerance, or 
“immunotolerance” that is seen with BVDV.   
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Interferons serve as the first line of defense against pathogens through their antiviral, anti-
proliferative, and immunomodulatory functions.  IFN-α/β are integral for the innate immunity by 
inhibiting viral replication in infected cells, whereas IFN-γ is the linking cytokine of the innate and 
adaptive immune system (Kadowaki et al., 2000).  The innate immune response ends in the production 
of type I interferons (α, β, and ω) which then activates the type II interferon (IFN-γ), where IFN-γ signals 
and initiates the beginning of the adaptive immune response.  The type I IFNs initiate the activation of 
ISGs through the JAK/STAT pathway (Malakhova et al., 2003).  Type I IFNs bind to its receptors on the 
cell surface of neighboring cells, leading to phosphorylation of STAT protein.  Once STAT enters the 
nucleus it then initiates transcription of IFN-inducible genes, such as gamma-interferon-inducible gene 
16 (IFI16), leading to the transcription of other interferon stimulated genes including ISG15 (Veeranki et 
al., 2011, Thompson et al., 2014).   ISG15 is a 15 to 17 kDa ubiquitin-like protein that exists either free or 
conjugated.  The conjugated form can target and conjugate with proteins for post-translation 
modification (ISGylation).  This ISGylation results in modulation of activity of various proteins and 
various innate anti-viral functions against both DNA and RNA viruses including destabilization of 
proteins, inhibition of viral replication, disruption of viral ubiquitination within host cells, or with certain 
viruses disruption of viral budding (Campbell et al., 2013, Cruz et al., 2017).  Thus, the innate immune 
system attempts to inhibit viral replication, but when it fails to do so, the innate system signals the 
adaptive immune system.    
IFN-γ is a type II interferon, produced by natural killer cells, as part of the innate immune 
system.  It is also produced by T helper and cytotoxic T lymphocytes as part of the adaptive immune 
response (Schoenborn et al., 2007).  After infection with ncpBVDV, IFN-γ measured in fetal blood spiked 
significantly twenty-two days after maternal infection, but for reasons that have yet to be identified, the 
IFN-γ was no different than controls at day 245 (Hansen et al., 2015).  In vitro infection of mononuclear 
cells with ncpBVDV also showed this same increase of IFN-γ after 48 hour exposure to the virus (Choi 
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2017).  Since IFN-γ is one of the many interferons produced during the innate immune response its 
production may indicate a functional innate immune response.  Additionally, IFN-γ is an important 
activator of macrophages and induces MHC molecule expression in the adaptive immune system.     
ADAPTIVE IMMUNITY    
The adaptive or acquired immune system is geared toward reacting against specific antigens.  
Immunological memory is created after the first exposure of the system to foreign antigens.  There are 
two divisions of the adaptive immune system: cell-mediated immune responses, directed by T cells, and 
humoral (antibody-mediated) immune responses, which is executed by B cells.  Both cells types 
originate in the bone marrow, but T cell progenitors migrate to the thymus to mature into T cells 
through a positive and negative selection process, which is described in greater depth in the Thymus 
Development section.   
There are several types of T cells, but the two major subsets are helper (Th) and cytotoxic (Tc) T 
cells which are of particular interest.  The Th cells recognize peptides presented on MHC class II 
molecules through the exogenous pathway, whereas Tc recognize peptides presented on MHC class I 
molecules through the endogenous pathway.  The binding of Tc then causes a release of cytokines that 
recruits and directs phagocytic cells to the foreign entity (Goddeeris et al., 1994, Blum et al., 2013).   
B cells are involved in the activation of other B cells through the interaction of CD4+ T cells and 
the MHC complex on the cell surface of B cells.  The B cell receptor binds to an antigen which is then 
internalized and processed and presented via MHC II complexes on the B cell surface to CD4+ T cells.  
These T cells then release cytokines that signals B cells to activate, proliferate, and differentiate into 
memory B cells, allowing for a quicker immune response the next time they come into contact with a 
foreign protein, or plasma cells which produce large amounts of antibodies directed at a specific foreign 








  Figure 2. Pathways of activation and regulation of the innate immune response. Modified from 







linked together as a heterodimer through a disulfide bond and together along with membrane bound 
IgM, they make up B cell receptor signaling complex (BCR) which is required for cell surface expression 
and signal transduction.  CD79a and -b are important for B cell maturation and survival and remain on 
the cell surface until differentiation of B cells into plasma cells (Fuentes-Pananá et al., 2006, Huang et 
al., 2011).   
ANTIGEN PROCESSING AND PRESENTATION 
For proper activation of T and B cells, antigen presentation is critical.   Presentation is 
established through the function of antigen presenting cells (APCs) like macrophages and dendritic cells.  
These APCs internalize, process, then present pathogen-derived peptides on the cell surface to allow 
CD4+ or CD8+ glycoproteins on the surface of T cells to bind.  Antigen processing and presentation is 
done through two pathways: major histocompatibility complex (MHC) I and II.  The genes of the MHC 
are highly polymorphic, which allows for recognition and binding of a variety of pathogens (Sette et al., 
1999). 
Systematically, MHC I and II glycoproteins bind to antigenic peptides and present them to T 
lymphocytes, referred to as cell-mediated immunity.  The MHC complex in bovine is referred to as the 
bovine major histocompatibility complex or the bovine leukocyte antigen (BoLa) gene locus (Spooner et 
al., 1979, Nascimento et al., 2006).  To avoid complexity, in this paper BoLa and MHC will be used 
interchangeably since their processes are identical.   
The MHC class I molecules follow the endogenous pathway (Figure 3), meaning that proteins 
present in the cytosol of antigen presenting cells are degraded into short peptides by the 
immunoproteasome via low-molecular-mass protein (LMP) 2, 7, or multicatalytic endopeptidase 
complex subunit 1 (MECL-1).  The immunoproteasome unit is upregulated by interferon gamma (IFN-γ).  
The LMPs and MECL-1 are structurally specific subunits to organs related to the immune system, such as 
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the spleen and thymus (Groettrup et al., 1997, Eleuteri et al., 2000, Ferrington et al., 2012).  When the 
subunits of the proteasome are upregulated, they play a role in stimulating the immunomodulator IFN-
γ, signifying their role in the antigen processing pathway (Eleuteri et al., 2000).   The degraded antigenic 
peptides are then transported into the endoplasmic reticulum (ER) by the transporter associated with 
antigen processing (TAP) 1 and 2 proteins.  The MHC class II transactivator (CIITA) is mainly associated 
with MHC class II function, but it also plays a role in the MHC class I promoter function, surface antigen 
expression, and gene induction (Martin et al., 1997, Nikcevich et al., 1999).  In the ER, the α chain and 
beta 2-microglobulin (β2-microglobulin) proteins will be assembled into a functional stable MHC I 
complex through various chaperone molecules.  The complex then allows for binding of the antigenic 
peptide within the ER.  This complex is then trafficked from the ER to the Golgi apparatus where post-
translational processes occur, and then finally to the surface membrane where it interacts with T cell 
receptors (TCRs) that are expressed on the surface of CD8+ T cells (Alberts et al., 2002b).  
The MHC I complex is especially important in cows during pregnancy.  It is imperative that 
maternal immunity not react to fetal antigens while still able to fight off any other infection that it may 
become exposed (De Mestre et al. 2010).  There are two classes of MHC I: the classical, highly 
polymorphic, and the nonclassical, nonpolymorphic.  The classical is able to present many different 
types of antigen, while the non-classical presents a “zero” antigen, an antigen that fills the MHC groove 
in order to keep natural killer cells from attacking it, which is how leukocytes recognize these aspects as 
being self (Rapacz-Leonard, Dąbrowska and Janowski 2014).  Antigen presenting cells can become 
infected with the BVDV virus in which more virus is produced.  These cells along with a multitude of 
different proteins can be altered after infection with BVDV which include: a variety of TLRs, both MHCs, 
and a number of other cytokines (Lee et al., 2006, Rajput et al., 2014).  While these changes were shown 
in adult cattle, their fetuses were not analyzed and thus can only speculate the changes in the fetus are  
due to the changes in the adult.  
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Figure 3. Antigen processing and presentation by the MHC class I pathway inside of an antigen 







The MHC class II molecules follow the exogenous pathway (Figure 4), in which antigen-
presenting cells (APCs), namely macrophages or dendritic cells, can take up antigen either through 
phagocytosis, endocytosis, or both.  In addition to being a signaling cytokine to activate the adaptive 
immune system, IFN-γ, produced by T lymphocytes and natural killer (NK) cells, has macrophage 
activation, anti-viral, and anti-proliferative properties.  IFN-γ has the ability to cause upregulation of 
both MHC class I and II molecules on cells (Kindt et al., 2007).  IFN-γ can then induce CIITA to 
transcriptionally induce most genes in the MHC class II pathway (Steimle et al., 1994, Muhlethaler-
Mottet et al., 1998).    
  Gamma-interferon-inducible lysosomal thiol reductase (GILT), also known as IFI30, is localized 
within endosomes where it plays a role in the unfolding and degradation of proteins (West et al., 2013).  
It is also constitutively expressed by APCs however, it is not regulated by CIITA, instead it is regulated by 
STAT1 and induced by IFN-γ (Hastings 2013).  In the ER a chaperone protein, invariant chain (Ii) binds to 
the MHC II molecule (Busch et al., 1996, Martin et al., 1997).  This complex is then moved through the 
Golgi to endocytic or phagocytic compartments where the Ii is degraded leaving an Ii-derived class II 
invariant chain peptide (CLIP) fragment.  The CLIP is then exchanged for antigenic peptide by HLA-DM, 
which is then transported to the surface membrane to allow for interaction with TCRs that are 
expressed on the surface of CD4+ T cells (Robinson et al., 2002, Kindt et al., 2007). 
It is important to mention that there are conflicting results shown previously between in vivo 
and in vitro studies.  For instance, one study measured in vitro IFN-γ production and MHC II complexes in 
bovine monocyte cells and Madin-Darby bovine kidney (MDBK) cells after infection with both 
noncytopathic biotype strains (ncpBVDV1 and ncpBVDV2).  In these cells, both the IFN production and 









Figure 4. Antigen processing and presentation by the MHC class II pathway. Modified from (Inaba and 







However, in vivo studies in young calves had the opposite results in which IFN production and 
MHC II complexes were shown to be increased (Smirnova et al., 2012, Smirnova et al., 2014, Choi 2017).  
The differences in these studies could be due to a difference between the models.  In the latter studies a 
different strain was used to infect cattle, but also the animals challenged were old enough to have a 
developed immune system, which could account for the increases measured.  
THYMUS AND BVDV  
The thymus is a target of BVDV and in order to gain an understanding of possible 
immunosuppressive or immunotolerant pathways, it is imperative to understand the development of 
the thymus as well as known effects of BVDV on various lymphoid tissues (Romero-Palomo et al. 2015).  
In ruminants, the thymus can first be visualized in one month old fetuses and lymphoid development 
occurs by day 42 of gestation (Goddeeris and Morrison 1994).  Colonization of T cells in the thymus 
occurs in a wave-like pattern where precursors enter the tissue, mature, and leave (Goddeeris and 
Morrison 1994).   
The thymus is a primary lymphoid organ where progenitor T cells migrate to mature.  Over 99% 
of the cells in the thymus are T cells, with the remaining being B cells, null cells, and other cells such as 
granulocytes, macrophages, and other hematopoietic cells (Shewen 1988). In the thymus, T cells 
undergo positive and negative selection process before being expelled into the peripheral blood (Figure 
5).  Positively selected T cells are able to recognize complex comprised of antigenic peptides and the 
MHC molecule, whereas cells that recognize self-antigen on MHC molecules are eliminated via apoptosis 
(Takaba et al., 2017).  There are three populations of T cells, which are defined by the expression of 
three surface molecules.  The CD4+ and CD8+ antigen identifies the MHC class II- and MHC Class I-
restricted subpopulations of αβ TCR+T cells, respectively.  The third population is CD4- and CD8- that is 
identified by the WC1 surface molecule and expresses the γδ T-cell receptor (TCR) (Howard et al., 1992).  
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These T cells can account for up to 60% of all lymphocytes in bovine peripheral blood, and they may 
serve a regulatory function (Guzman et al., 2014).  What separates these T cells from other lineages is 
their ability to become activated by directly binding to antigens, without interaction with MHC 
complexes.  
During BVDV infection, the virus is found in lymphocytes, lymphoid follicles, and the cortex of 
the thymus (Liebler-Tenorio et al., 2004).  Following infection, thymic lymphoid depletion has been 
commonly reported, but the mechanism behind this has not been fully investigated (Ohmann 1982, 
Raya et al., 2012, Falkenberg et al., 2014, Romero-Palomo et al., 2015, Falkenberg et al., 2017).  
Histological cellular depletion of the thymus appears to correlate with clinical presentations in which 
infected animals with clinical disease had the most pronounced cortical atrophy, followed by acutely 
infected calves.  However, clinical PI calves had similar thymic patterns to control calves (Falkenberg et 
al., 2017).  One theory behind this lymphoid depletion is related to thymic epithelial cells (TECs), which 
are in the cortex of the thymus and play a role in positive selection of maturing lymphocytes.  Without 
the signal from TECs to allow for continued maturation of lymphocytes, the lymphocytes undergo 
apoptosis (Raya et al., 2015).  TECs are target cells of BVDV and can produce cytokines that stimulate the 
proliferation of lymphocytes (Raya et al., 2015).  Since BVDV tends to translocate to epithelial cells early 
in the course of the disease, maturation of lymphocytes may be restricted and increased thymic atrophy 
may occur.  Even with the depletion of cells in the thymus, peripheral blood mononuclear cells (PBMCs) 
were still found to elicit an MHC class I- and II-restricted T cell response indicating that BVDV may not 
cause a complete suppressive effect of the antigen processing and presentation pathway (Glew et al., 
2001).     
 Previous research has indicated that there is a function innate immune response in both blood 
and spleen, however the thymus tells a different story.  Atrophy is commonly seen in the thymus and  
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thus dysgenesis of the thymus during gestation leads to suppression of the innate and adaptive immune 
























Figure 5. Illustration of T cell maturation in the thymus.  This illustration follows a hematopoietic 
precursor in the cortex and medulla to lymphoid progenitor and the stages of double negative (DN) for 
CD4-CD8- then maturing to double positive (DP) for CD4+CD8+ before becoming committed to the end 
stage of CD8+ and CD4+ expressed T-cells prior to emigration to the peripheral blood.  Modified from 







INNATE AND ADAPTIVE IMMUNE RESPONSES AFTER BOVINE VIRAL DIARRHEA VIRUS INFECTION IN THE 
FETAL THYMUS 
INTRODUCTION 
 Infection with BVDV, a Pestivirus in the family Flaviviridae, leads to significant economic losses 
for cattle producers in all bovine sectors worldwide (Larson et al., 2002, Moennig et al., 2005, Pinior et 
al., 2017, Richter et al., 2017).  BVDV is a small, enveloped, RNA virus that is classified into two 
genotypes.  Each genotype has two biotypes which is based on their lytic activity in cell culture - 
cytopathic (cp) and noncytopathic (ncp) (Gillespie et al., 1961).  Both BVDV biotypes can cause acute 
infection in immunocompetent animals with diverse clinical presentations, ranging from subclinical 
disease, to fever, nasal or ocular discharge, to more sever systemic disease involving reproductive loss, 
including early embryonic death, abortion, and stillbirth (Childs 1946, Brownlie et al., 1987, Lanyon et 
al., 2014).  BVDV has a multiple organ tropism and previous data has illustrated that infection affects 
fetal growth and normal development of multiple organs. The immune function in blood, spleen, liver 
and other organs is also altered due to persitent infection with BVDV (Smirnova et al., 2008, Hansen et 
al., 2015).  When infection occurs after development of the immune system, which is around day 160, 
the animal develops a transient infection (TI) that can eventually be cleared through seroconversion 
(Done et al., 1980, Hanon et al., 2014).   
 Cows have an epitheliochorial placenta in which placentomes are mutlifocal and allow for 
nutrient exchange between dam and fetus (Brownlie et al., 1987).  The BVDV virus can be vertically 
transferred from dam to fetus at any stage of gestation via the placenta, but only the noncytopathic 
biotype has been reported to establish a persistent infection (PI) in the fetus (McClurkin et al., 1984, 
Virakul et al., 1988).  Once in the fetus, the virus can replicate in a variety of cell types including 
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epithelial cells, monocytes and macrophages, thymocytes and lymphocytes, and dendritic cells; albeit 
the virus tends to replicate in epithelial cells and macrophages earlier than lymphocytes (Bolin 2002, 
Bachofen et al., 2013).  The replication of BVDV in the cells that it has a predilection for, may cause the 
changes in the immune responses that have been previously reported. 
 The innate immune response is initiated by retinoic acid inducible gene I (RIG-I), which is an RNA 
helicase that recognizes viral RNA in the cytosol (Loo and Gale 2011).  Viral recognition receptor, RIG-I, 
then leads to further activation of interferon regulatory factors 3 and 7 (IRF), as well as nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-kB) pathways, which eventually lead to transcription 
of type I and II interferons (Figure 2).  The type I interferons lead to activation and of interferon 
stimulated genes (ISGs).  ISG15, amongst other ISGs, the type II interferons, as well as tumor necrosis 
factor-alpha (TNF-α) lead to the initiation of the adaptive immune response (Loh et al., 1992, Sentsui et 
al., 1998, Kadowaki et al., 2000, Samuel 2001, Taniguchi et al., 2001, Charleston et al., 2002).  Following 
the type I IFN response, IFN-γ and TNF-α initate the adaptive immune response for a more robust and 
specific response to the viral infection.  
 IFN-γ, an initiator of the adaptive immune response pertaining to the MHC class I pathway, is 
able to increase the expression of the immunoproteasome which is made up of LMP2, -7, and MECL-2 
(Niewerth et al., 2014).  The immunoproteasome processes antigens to make peptides which then 
translocate into the endoplasmic reticulum via TAP proteins.  These peptides then bind to MHC 
complexes where they are presented on antigen presenting cells (APCs) to CD8+ T cells (Groettrup et al., 
1997, Eleuteri et al., 2000, Ferrington and Gregerson 2012).  
The following experiments were designed to determine the timing of persistent infection in 
thymic tissue as well as the periods when the innate and adaptive immune pathways are affected by 
viral infection.  As seen in the previous viral titer data (Figure 1), there is a viral titer peak in fetal blood 
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on day 97 of gestation, which then incurs a robust drop in viral mRNA at days 192 and 245 of gestation.  
This decrease between days 97 and 192 of gestation may indicate a partially active immune system.  We 
hypothesize that BVDV fetal infection during early gestation results in dysgenesis of the thymus, leading 
to a suppressed innate and adaptive immune responses in the fetus against BVDV infection.  The aim 
was to identify at what point the fetal immune response is no longer adequately responding to the virus 
as well as to identify which genes and proteins, in both the innate and adaptive immune systems, are 
malfunctioning. 
 MATERIALS AND METHODS 
Animals 
Animal experiments were performed following the experimental design previously described 
and below (Smirnova et al., 2008, Smirnova et al., 2012).  All animal experiments were approved by the 
Institutional Animal Care and Use Committee at Colorado State University and the University of 
Wyoming.  Naïve Hereford heifers were purchased from a source that did not vaccinate against BVDV 
and were serologically negative for BVDV.  Heifers were confirmed negative for BVDV using an ear notch 
sample for ELISA capture sent to IDEXX Laboratories (Westbrook, ME, USA) as well as a standard serum 
neutralization assay.  Heifers were re-tested prior to BVDV inoculations to confirm negativity. Estrous 
cycles were synchronized and heifers were artificially inseminated with BVDV-free semen around 12 
months of age.  Ultrasound examination confirmed pregnancy on days 32 and 70 of gestation. 
Experimental design: BVDV infection and fetal collections 
 Two experiments were performed, as previously described, experimental design for both is 
depicted in Figure 6 (Smirnova et al., 2008, Smirnova et al., 2012).  Briefly, experiment 1 used 18 
pregnant heifers, naïve for BVDV, and they were inoculated with a 2 ml aliquot of 4.4 log10 TCID50/ml of 
ncp BVDV2 strain 96B222 intranasally to create infected fetuses or were sham inoculated with culture 
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media as controls.  Animals were inoculated with virus or media on day 75 of gestation to generate PI or 
control fetuses or they were inoculated on day 175 to generate TI or control fetuses (n=6 control/6 PI/ 
6TI).  Fetuses were collected by Cesarean section on day 190 of gestation for experiment 1 and day 192 
of gestation for experiment 2. 
The second experiment used the same dose and route of ncp BVDV for inoculation.  Animals 
were inoculated on day 75 of gestation and fetuses were collected by Cesarean section on days 82, 89, 
97, 192, and 245 of gestation (n = 4 control/4 PI fetuses for days 82, 89, 97, 192, and 245; n = 4 control/3 
PI fetuses for day 245: one PI fetus in the 245 day group was lost due to abortion prior to collection for 
reasons that were not related to the experimental infection).  Fetal tissues for RNA and protein analysis 
were snap frozen in liquid nitrogen and stored at -80oC.       
 
 
Figure 6. Experimental design to examine fetal response to persistent infection with ncpBVDV.  Heifers 
were artificially inseminated (AI) on day 0.  Confirmed pregnant heifers were infected with ncpBVDV 
type 2 viral strain intranasally on days 75 and 170 of gestation to generate PI and TI fetuses, 
respectively, or they were kept BVDV-naïve to generate control, uninfected fetuses.  Cesarean sections 
were performed on day 89, 97, 190, and 245 of gestation to collect fetuses.  Modified from (Hansen et 




RNA Extraction and RT-qPCR  
Total RNA from 70 mg of frozen thymus tissues was isolated with TRIzol reagent according to 
manufacturer’s instructions (Invitrogen, USA).  The isolated RNA was treated with DNAase I (Qiagen, 
Germantown, MD) and was purified using RNeasy MiniElute Cleanup Kit (Qiagen, USA).  RNA 
concentration, 260/280 and 260/230 ratios were measured using NanoDrop 1000 Spectrophotometer 
(ThermoScientific, Rockford, IL).  All amplicons were sequenced (GENEWIZ, LLC) to confirm identity of 
each target gene.  Primers were designed to generate 90 to 200 bp amplicons and were optimized for 
melting point as well as lack of self-annealing or folding at high temperatures.  Analysis of efficiency of 
amplification for each primer pair was completed.  Primer efficiencies were performed in fetal thymic 
tissues and considered acceptable if between 90 to 120 percent.  Primer sequences and their accession 
numbers are listed in Table 1. One microgram of RNA was then reverse transcribed to synthesize cDNA 
using iScript ™ Reverse Transcription Supermix for RT-qPCR (Bio-Rad, Hercules, CA).  Reverse 
transcription (RT) was performed according to manufacturer protocol.  Reverse transcription 
quantitative polymerase chain reaction (RT-qPCR) was performed with iQ ™ SYBR® Green Supermix 
according to manufacturer’s instructions (Bio-Rad, Hercules, CA,).  Briefly, upon generation of dsDNA, 
iQ™ SYBR® Green Supermix intercalates between strands of DNA as they are formed.  With increasing 
copies of DNA, the signal is increased.  Synthesized cDNA was then diluted 5-fold with RNAase free 
water.  Final primer concentrations were 5 µM.  Technical duplicates of each reaction was placed on the 
same plate.  Three biological replicates were also performed.  
The RT-qPCR reaction was performed in a 384-plate format and conducted at one cycle of 95oC 
for 3 minutes, 40 cycles of 95oC for 30 s, 58oC for 30 s and 72oC for 15 s with a final 5 minute elongation 
using a LightCycler-480 Instrument (Roche, Basel, Switzerland).  Gene expression was calculated after 
normalization with 18S ribosomal RNA (18S rRNA), an endogenous control, using the comparative ∆Ct 
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method and was presented as relative expression (2-∆Ct).  Upon completion of RT-qPCR, amplification 
melting curve analysis was performed to assess the quality of amplification.  RT-qPCR was evaluated 
based on MIQE guidelines (Bustin et al., 2009).   
Table 1. RT-qPCR primer sequences. F – forward, R – reverse 
Target gene Accession number Primer sequences 
Housekeeping Genes 
GAPDH DQ403066 F: TGACCCCTTCATTGACCTTC 
R: CGTTCTCTGCCTTGACTGTG 
18S  NR_036642.1 F: GAACGAGACTCTGGGCATGC 
R: CTGAACGCCACTTGTCCCTC 
Innate Immune Genes 
RIG-I XM_580928.8 F: CAGGAAGATCCTGGACCCTA 
R: TTTTTCTTGGCCTGAATGTG 
IRF7 XM_015461322.1 F: GCCTCCTGGAAAACCAACTT 
R: CCTTATGAGGGTCGGTAGGGG 
NF-KB XM_010819902.2 F: CGAGGTTCGGTTCTACGAGG 
R: TGCAGGAACACGGGTTACAGG 
IFNβ XM_015464447.1 F: TCCAGCACATCTTCGGCATT 
R: TTCCCTAGGTGGGGAACGAT 
STAT1 CK849770 F: CCTGTATCTGGGCAGAGGAT 
R: CCAAAAGCTAATTCTCCCAAGA 
IFI16 CK952947 F: GGAGTGATGGAAGTCGTGGT 
R: CCCACTTTCTCCCAATTCAA 
ISG15 NM_001009735.1 F: GGTATCCGAGCTGAAGCAGTT 
R: ACCTCCCTGCTGTCAAGGT 
Adaptive Immune Genes – MHC Class I 
LMP2 NM_001034388.2 F: ATCTACCTGGCCACCATCAC 
R: AGGAGAGTCCGAGGAAGGAG 
TAP2 NM_174222.2 F: TGGAGCTGGATTTAGACCGTG 
R: GGCAAAGCTCTGTTCGTCAA 
β2M AC_000167.1 F: AFTAAGCCGCAGTGGAGGT 
R: CGCAAAACACCCTGAAGACT 
CD8a NM_174015.1 F: TACATCTGGGCTCCCTTGGT 
R: CCACAGGCCTGGGACATTTG 
CD8b NM_001105344.2 F: AGCTGAGTGTGGTTGATGTTCT 
R: TTCTGAGTCACCTGGGTTGG 
Adaptive Immune Genes – MHC Class II 
CIITA XM_005196914.3 F: AGTCTGGAAGTTGCTGCCGTC 
R: CACTGTCCACTGCCTTGGG 
GILT (IFI30) AY581199.1 F: GCATGCAGCTCTTGCACATC 
R: GGCCCCAAGAGTTCTTACCC 
CD4 NM_001103225.1 F: GGGCAGAACGGATGTCTCAA 
R: ATAGGTCTTCTGGAGCCGGT 
B Cell Gene 




IFN Inducible Genes 
CXCR6 CB170970 F: CAGGTGCCTGACAGAAATGA 
R: CTTCCAGGGTCAAGCAAAGA 
CXCL10 CB533091 F: ACACCGAGGCACTACGTTCT 
R: TAAGCCCAGAGCTGGAAAGA 
CXCL16 CK770974 F: CTTGTGAGGGCAGATTGTGA 
R: GGTCAATAGCTGGTTAGTTGTGAA 
BVDV Cell Receptor Gene 




 Protein was generated from thymic tissues homogenized in 1X RIPA buffer and Halt™ protease 
and phosphatase single-use inhibitor cocktail according to manufacturer instructions (ThermoScientific, 
Rockford, IL).  Concentrations were measured using the Pierce™ BCA Protein Assay Kit (ThermoScientific, 
Rockford, IL) and analyzed in a BioTek Synergy 2 reader (Winooski, VT).  Proteins were subjected to 12% 
SDS-PAGE made from TGX™ FastCast™ Acrylamide Solutions Kit (Bio-Rad, Hercules, CA), transferred to 
nitrocellulose membranes, and blocked with Bio-Rad Blocking Buffer (Bio-Rad, Hercules, CA)/Tris-
buffered saline-Tween 20 (TBS-T) at room temperature for one hour.  Western blotting was carried out 
using the following dilutions of primary antibodies in blocking buffer: 1:1,000 anti-IRF7 (rabbit IgG; 
abcam ab62505), 1:1,000 anti-CD4 (mouse IgG, abcam ab25804), 1:25,000 5F10 mouse monoclonal anti-
ISG15 antibody (Austin et al., 2004) and 1:2,000 β-actin (mouse monoclonal antibody conjugated to 
HRP, Santa Cruz BioTechnology sc-47778).  Washed blots were then incubated in 1:2,000 dilutions in 1% 
Bio-Rad Blocking BufferTBS-T of the appropriate secondary antibody-horseradish peroxidase (HRP) 
conjugate (Santa Cruz BioTechnology).  Clarity™ Western ECL Blotting Substrate (Bio-Rad, Hercules, CA) 
was used to activate the HRP and imaging was performed using Molecular Imager ChemiDoc™ XRS+ with 




Morphogenesis of Thymus during Bovine Fetal Development and Effect of in utero BVDV Infection 
 Thymus samples, collected previously (Smirnova et al. 2008, Smirnova et al. 2012) and fixed for 
48 hours in 10% neutral-buffered formalin, followed by routine processing for paraffin-embedding, were 
sectioned (4-5 µm) and stained with eosin and hematoxylin (H&E).  Microscopic assessment was 
performed with special attention to the components of the reticulo-endothelial network, myeloid, and 
lymphoid cells, including when and where the latter two cell types appear in the organ primordium.  For 
the thymus, the relative cortical-to-medulla ratio was assessed, including full encirclement of the 
medulla by cortical thymocytes.  Additionally, attention was paid to myoid cells and Hassall’s corpuscles 
in terms of appearance, frequency, and size.  Histopathology was performed in collaboration with Helle 
Bielefeldt-Ohmann at the University of Queensland.  
Statistical analysis  
 Statistical analysis of data obtained by RT-qPCR was performed in GraphPad Prism 7.  For BVDV, 
the control group was expected to have very low (or no) expression.  This is seen in summary statistics 
and graphs, but it creates an “artifact” in the analysis due to essentially zero variability and sample size 
(especially at day 245 of gestation), thus a Wilcoxon test was used to compare PI versus control at each 
day separately.  For day 190 of gestation and analyzing BVDV, a Kruskal-Wallis analysis was used to 
compare the three different groups (Control, PI, and TI).  For all other genes, a two way ANOVA was 
used to compare control and PI for all days.  For genes at day 190, a one way ANOVA was used to 
compare control, PI, and TI.  Differences between groups (infected, day, and infected/day) were 
considered significant when p-value was less than 0.05.  Data are presented as mean ± standard error.  






Infection with BVDV induces innate gene immune responses in the fetal thymus of TI, but not PI fetuses 
Thymus RIG-I mRNA was significantly increased in the TI fetuses compared to control (P ≤ 0.001) 
and PI (P ≤ 0.0001) at day 190 of gestation (Figure 7A).  The TI fetuses were only collected at day 190 of 
gestation.  RIG-I was not significantly different in control versus PI fetal thymic tissue at day 89, 97, or 
245 of gestation (Figure 7A).   
IRF7 mRNA was significantly increased in the TI fetuses compared to control (P ≤ 0.001) and PI (P 
≤ 0.0001) fetuses at day 190 of gestation (Figure 7B).  There were no significant difference between 
control and PI at day 89, 97, or 245 of gestation (Figure 7B).  NF-kB mRNA was significantly increased in 
the PI fetuses compared to the control fetuses (P ≤ 0.01) at day 97 of gestation, whereas the PI fetuses 
were significantly decreased compared to the control (P ≤ 0.01) and TI (P ≤ 0.0001) fetuses at day 190 of 
gestation (Figure 7C).  The TI fetuses were also significantly increased compared to the control fetuses (P 
≤ 0.01) also at day 190 of gestation (Figure 7C).    
IFNβ mRNA was significantly decreased in the PI fetuses compared to control (P ≤ 0.05) and TI (P 
≤ 0.0001) fetuses at day 190 of gestation (Figure 7D).  There were no IFNβ differences between control 
and PI fetuses at day 89, 97, or 245 of gestation (Figure 7D).  When analyzed in BVDV fetal thymuses 
there was no change of ISG15 gene expression at any day of gestation, except in the TI fetus where the 
TI is significantly higher than control (P ≤ 0.01) and PI (P ≤ 0.01) fetuses at day 190 of gestation (Figure 
7E).   
Western blot analysis of innate immune responses after BVDV infection in fetal thymus 
  IRF7 from fetal thymus was measured at day 89, 97, 190, and 245 gestation.  There was no 
difference in IRF7 after BVDV infection at day 89, 97, 190, or 245 of gestation (Figure 8). Protein was  
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Figure 7. Responses of innate immune response genes in the fetal thymus after maternal inoculation 
with ncpBVDV at day 75.  (A) RIG-I mRNA; (B) IRF7 mRNA; (C) NF-kB mRNA; (D) IFNβ mRNA; and (E) 
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Figure 8. Western blots of IRF7, normalized to β-actin from day (A) 89, (B) 97, (C and D) 190, (E) 245 and 
























Figure 9. Increased protein expression in TI fetuses at day 190 of gestation after maternal inoculation 
with ncpBVDV.  Western blots of ISG15 at day 190 (A and B) followed by (C) the ratio of the conjugated 
ISG15 and β-actin and (D) the ratio of the free ISG15 and β-actin.  Data are presented as mean ± SE.  * P 

















normalized to β-actin (Figure 8F).  The IRF7 protein data does not correlate with day 190 of gestation 
mRNA.  ISG15 exists in both a conjugated and free form.  Protein measured from 37 kDa and above is 
considered conjugated and the free form is at 17 kDa (Figure 9A).  The TI fetuses conjugated form of 
ISG15 was significantly higher than both the control (P ≤ 0.01) and PI (P ≤ 0.05) fetuses at day 190 of 
gestation (Figure 9B).  However, the free form of ISG15 was not significantly different from control (P ≤ 
0.36) or PI (P ≤ 0.37) thymuses, but it does follow the same trend that the TI fetuses have an increased 
amount of protein compared to control and PI fetuses at day 190 of gestation (Figure 9C).  
Expression of IFN induced genes in fetal tissues 
Type I and II IFNs are able to initiate activation of various interferon inducible genes which serve 
various roles in both immune pathways.  The genes that we studied that are associated with these 
pathways include STAT1, IFI16, CXCL10, CXCL16, and CXCL6.  RT-qPCR was performed on these listed 
genes at days 89, 97, 190, and 245 of gestation.   
STAT1 mRNA concentrations did not change on days 89, 97, 190, or 245 of gestation between 
any treatment group (Figure 10A).  Whereas RT-qPCR showed a significant difference between PI and 
control (P ≤ 0.001) and PI and TI (P ≤ 0.05) fetuses at day 190 of gestation for IFI16 (Figure 10B).  There 
were no other significant differences between treatment groups at day 89, 97, or 245 of gestation for 
IFI16.    
 Chemokines CXCL10, CXCL16, and CXCR6 are generally induced by IFN-γ.  There was no 
significant difference between fetal thymuses after maternal BVDV infection in any treatment group at 
day 89, 97, 190, or 245 of gestation for CXCL10 (Figure 10C).  However, both chemokines CXCL16 and 
CXCL6 showed significant differences at day 190 of gestation (Figure 10D and E).  For CXCL16 the PIs 
were significantly lower than both the control (P ≤ 0.01) and TI (P ≤ 0.05) fetuses at day 190 and for  
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Figure 10. Concentrations of mRNA for IFN-γ induced genes in fetal thymus after maternal inoculation 
with ncpBVDV.  Gene expression of IFI16, CXCL16, and CXCR6 mRNA, significantly decreased in PI fetal 
thymus on day 190 when compared to control and TI fetuses.  (A) STAT1 mRNA, (B) IFI16 mRNA, (C) 
CXCL10 mRNA, (D) CXCL16 mRNA, and (E) CXCR6 mRNA.  Data are presented as mean ± SE.  * P ≤ 0.05, 
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CXCR6 the PI was significantly lower than control (P ≤ 0.01) fetuses however, there was too much 
sample to sample variablity in the TI fetuses to show a significant difference.   
Downregulation of genes along the MHC class I (BoLa) Pathway in response to fetal persistent infection 
in the thymus  
No differences were found for IFN-γ for mRNA measurement between control and PI groups on 
any of the days of gestation analyzed (Figure 11A).  The immunoproteasome is a beginning step of 
antigenic peptide breakdown.  RT-qPCR was performed on thymus tissue for various genes along the 
MHC class I Pathway.  After maternal BVDV infection, there is an increase of fetal thymic LMP2 mRNA of 
persistently infected fetuses compared to the control group at day 97 of gestation (P ≤ 0.001), but is 
then downregulated at day 190 and 245 of gestation (P ≤ 0.01).  The TI fetuses were also significantly 
increased compared to the PI (P ≤ 0.05), but not different than the sham infected controls (Figure 11B).    
The TAP 1 mRNA was significantly increased in PI fetuses at day 97 (P ≤ 0.05), but the day 190 
samples showed a decrease of PI fetuses compared to the control group (P ≤ 0.0001).  The day 245 PI 
fetuses were trending toward a decrease, but they were not significantly different (P = 0.09) (Figure 
11C). β2M mRNA was significantly decreased at day 190 and 245 in the PI fetuses compared to the 
control group (P ≤ 0.01) and TI fetuses compared to PI fetuses at day 190 (P ≤ 0.0001) (Figure 11D).  The 
CD8a and CD8b mRNA from thymus tissue at all days of gestation tested had the same pattern of 
change.  The CD8a gene was significantly decreased in PI compared to the control (P ≤ 0.01) fetuses at 
day 190 gestation of PI animals as well as in the PI compared to TI (P ≤ 0.001) fetuses (Figure 12A).  On 
day 245, CD8a was significantly decreased in the PI compared to control (P ≤ 0.001) fetuses.  The CD8b 
gene was also significantly decreased in PI animals compared to control (P ≤ 0.05) and TI (P ≤ 0.01) 
fetuses at day 190 of gestation (Figure 12B).  Day 245 PI fetuses were also significantly decreased 




Figure 11.  Responses of adaptive immune response genes in the fetal thymus after maternal inoculation 
with ncpBVDV.  (A) IFN-γ mRNA, (B) LMP2 mRNA, (C) TAP1 mRNA, and (D) β2M mRNA.  Data are 
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Figure 12. Responses of CD8a and CD8b in the fetal thymus after maternal inoculation with ncpBVDV.   
(A) CD8a mRNA and (B) CD8b mRNA.  Data are presented as mean ± SE.  * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 
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Downregulation of genes along the MHC class II Pathway in response to fetal persistent infection in the 
thymus 
RT-qPCR was performed on thymus tissue for CIITA, GILT, and CD4+ mRNA on four selected time 
points representing the course of the establishment of fetal persistent infection at days 89, 97, 190, and 
245.  There was a significant increase in CIITA mRNA concentration at day 97 in the PI fetuses compared 
to control groups, but CIITA mRNA at significantly decreased in both day 190 and 245 compared to 
control groups (Figure 13A).   
There was a significant increase in GILT mRNA concentration in PI versus the control group at 
day 97, with no differences at day 89 (P = 0.66), 190 (P = 0.98), or 245 (P = 0.80) (Figure 13B).  CD4 had 
decreased gene expression at day 190 and 245 in PI fetal thymus.  CD4 was significantly lower in fetal PI 
thymuses at day 190 compared to both the control (P ≤ 0.0001) and TI (P ≤ 0.001) samples (Figure 13C).  
Following the RT-qPCR data, CD4 protein concentration was evaluated using Western blot.  CD4 
from days 89 (P = 0.99), 97 (P = 0.99), 190 (P = 0.43), and 245 (P = 0.99) of gestation did not show any 
significant difference between the treatment groups (Figure 14).  It is important to note that this did not 
correspond with the mRNA data. 
Additional genes measured in the thymus after BVDV maternal infection using RT-qPCR 
RT-qPCR of CD79b in the fetal thymus after maternal BVDV infection showed significant 
difference between PIs and control (P ≤ 0.05) and PI and TI (P ≤ 0.01) fetuses at day 190 of gestation 
(Figure 15).  There were no other differences between treatments at day 89, 97, or 245.  The BVDV 
mRNA viral titer using RT-qPCR was also measured at days 89, 97, 190, and 245 of gestation.  BVDV 
mRNA levels were not expressed in any of the control fetal thymus tissue. The PI BVDV mRNA relative 






Figure 13.  Responses of adaptive immune response genes in fetal thymus after maternal inoculation 
with ncpBVDV.  (A) CIITA mRNA, (B) GILT mRNA, and (C) CD4 mRNA.  Data are presented as mean ± SE.  * 
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Figure 14. Protein expression of CD4 in fetal thymus after maternal inoculation with ncpBVDV.  Day (A) 
89, (B) 97, (C and D) 190, and (E) 245 of gestation.  Figure (F) is the ratio of CD4 to β-actin at each day.    






































    
 





of the mean.  There was no significant difference in the BVDV receptor, CD46, expression from fetal 
thymus after maternal BVDV infection at day 89, 97, 190, or 245 (Figure 16).  
Morphogenesis and Histology of thymus during bovine fetal development and the effect of in utero BVDV 
infection 
Fetal thymuses from control, TI, and PI fetuses were evaluated at days 82, 89, 97, 190, and 245 
of gestation for morphological differences after maternal infection with BVDV.  One day 82 infected, two 
day 89 control, and one day 89 infected thymus were examined (Figure 17 A & B).  These four thymuses 
have clearly delineated cortex and medulla.  The cortex is relatively narrow compared to later fetal 
stages, and has a “leaflet”-like outline, whereby the medulla in some places is directly adjacent to the 
interstitial parenchyma.  However, the cortical cell density is comparable to that of later fetal stages.  
The medulla contains well developed Hassall’s corpuscles and rare myoid cells.  Extramedullary 
hematopoietic activity is present in the septae between the cortical “leaflets”. 
 Four control and four PI fetal thymuses from day 97 are similar in morphology to the day 89 
tissue, except for a slightly greater variation in the cortex-to-medulla ratio (Figure 17 C &D).  However,  
there are no discernible differences between thymuses from the control or PI fetuses at day 97 of 
gestation.   
 At day 190, the morphology of the tissue has attained almost a neonatal appearance, with the 
cortex having expanded to completely surround the medulla and the cortico-medullary ratio being ≥ 2 
(Figure 17 E & F).  Six-fetal thymi were examined from control, TI, and PI maternally infected animals.  
The medulla contains large, often complex Hassall’s corpuscles, large numbers of myoid cells and 
eosinophilic granulocytes.  The latter can be seen throughout the medulla, but appears in highest 









Figure 15. Expression of CD79b mRNA in response to BVDV.  CD79b was measured in fetal thymus at day 
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Figure 16. There are no CD46 gene expression changes in fetal thymus collected at day 89, 97, 190, or 
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Figure 17. H&E Staining of fetal thymus comparing control and PI at various days of gestation.   (A) 
Control and (B) PI day 89;  (C) Control and (D) PI day 97; (E) Control and (F) PI day 190 (G) Control and 












eosinophilic cytoplasm, either homogenous or with finely fibrillar patterning.  The almost euchromatic 
nucleus is round and centrally located or more oval and acentric.  There may be a small amount of 
chromatin clumping along the nuclear membrane and occasionally a small nucleolus is present.  These 
cells may in some cases be considered “single cell” Hassall’s corpuscles.  There are no discernible 
differences between the control, TI, or PI fetuses with regard to the thymus morphology at day 190.  
Four control and 3 infected fetal thymi were evaluated from day 245 of gestation.  The thymus appears 
as is normal for neonates.  There are no discernible differences between the control and PI fetuses, 
except that one infected thymus may have more myoid cells, but morphometry would be required to 
ascertain or refute this impression.    
DISCUSSION  
BVDV is a remarkable virus because of its ability to evade the immune system and continuously 
spread through herds by only a single persistently infected animal.  In this study, we have shown that 
BVDV affects the innate and adaptive immune systems in the fetal thymus after transplacental infection. 
The thymus is a target organ for BVDV and it is also a primary lymphoid organ which serves as the 
primary site of T cell maturation.  It is mostly associated with the adaptive immune response, but it also 
has some functionality related to innate immunity.  Innate immunity is a non-specific defense 
mechanism and is initiated soon after antigens enter the body.  The innate immune response is the first 
line of defense to fend off foreign antigens, while the adaptive immune response focuses on the antigen 
processing and presentation, mediation of viral replication, production of antibodies, and co-stimulatory 
signals.  It has been shown that after infection of BVDV, maternal blood viremia is first detected at day 
82 and cleared by day 89, which is 2 weeks after initial inoculation however, viremia in PI fetal blood is 
first detected at day 89, peaks at 97, and then significantly decreases by day 192 and 245 of gestation, 
but is not cleared (Figure 1).  This observation is of interest because this pattern of viremia indicates a 
functional adult immune response, but a compromised fetal immune response.    
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Infection with BVDV induces innate immune responses in the fetal thymus of TI, but not PI fetuses 
A functional innate immune response in blood and spleen has previously been described, but as 
to why it is not able to resolve persistent BVDV infections is unclear (Hansen et al., 2010, Hansen et al., 
2015).  However, this does not explain the attenuation in viral titer.  For this reason, we suspected that 
the innate immune response might be mostly intact.  To test this idea, five early response genes to viral 
infection (IFNβ, NF-kB, RIG-I, IRF7, and ISG15) were analyzed in fetal thymus using real-time PCR within 
the innate immune system at days 89, 97, 190, and 245 of gestation.  All genes evaluated had an 
increased gene expression (mRNA) in TI fetal thymuses at day 190 of gestation.  The IRF7 protein 
concentration was also increased in the TI fetuses at day 190.  TI fetuses have a competent immune 
system and a normal response to foreign antigens as expected.  However, it is not yet known whether 
this can have long lasting detrimental effects postnatally.  There was only one gene with increased gene 
expression in PI fetal thymuses, NF-kB, this gene only had increased mRNA at day 97 of gestation, which 
coincides with an in vitro study in MDBK cells in which BVDV increases translocation of NF-kB to the 
nucleus which leads to pro-inflammatory responses that regulate the host-virus interaction (Zahoor et 
al., 2010, Fredericksen et al., 2015).  However, we saw decreased expression of NF-kB in the PI fetal 
thymus at day 190 which significantly alters the normal host-virus interaction.  The initial increase of NF-
kB at day 97 of gestation may lead to decreased receptor sensitivity and attenuation of signaling 
cascades through the accumulation of dimers which could explain the subsequent decrease in gene 
expression at day 190 and 245 of gestation.    
IFNβ is a type I IFN that activates other molecules to prevent the virus from replicating, creating 
an “anti-viral” state within the cell.  IFNβ gene expression was diminished in the PI thymus at day 190.  
In a previous in vivo study, naïve heifers were inoculated with ncpBVDV type 2.  IFNβ mRNA was 
measured at various days of gestation in fetal blood, caruncles, and cotyledons.  The only difference 
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seen with this gene was an increase in PIs in the cotyledon at day 192 of gestation (Smirnova et al., 
2012).  However, another study exposed adult PBMCs to BVDV type 1 and IFNβ was found to be 
diminished compared to control samples (Weng et al., 2015).  These two studies may show conflicting 
results because they were exposed to different types of BVDV and studies were done either in vivo or in 
vitro.  However, IFNα/β secretion in the thymus is induced by dendritic cells and the decreased IFNβ in 
the thymus may be because of a shift of the various cell types within the thymus, or a decrease in 
transcription within cell types, but immunohistochemistry will be needed to test this theory (Colantonio 
et al., 2011).  NF-kB may be up at the initial exposure to the virus, but since there is no increase in IFNβ, 
the ability for NF-kB to induce IFNβ may be inhibited.   
RIG-I, IRF7, and ISG15 were not statistically different in control compared to PI fetal thymuses at 
any day of gestation.  RIG-I is a cytosolic pattern recognition receptor that is essential for antiviral 
immunity in the innate immune response.  Various viruses (dengue virus, procaine reproductive and 
respiratory syndrome virus, the hepatitis C virus, and porcine epidemic diarrhea virus) are able to mask 
their PAMP signatures preventing RLR activation (Zinzula et al., 2013, Schulz et al., 2016).  IRF7 is 
expressed in mature thymocytes and in a tissue that is still developing, its expression may be low due to 
the immaturity of the thymus and thymocytes which may explain why there is no change in gene 
expression or protein concentration (Colantonio et al., 2011).  ISG15 is known to be secreted from 
various immune and nonimmune cells and is induced by IFNs, viral infection, and bacterial endotoxins 
thus with no increase in IFNs, ISG15 is not expected to change (Osiak et al., 2005).  These data analyses 
are summarized in Figure 18.    
IFN induced genes in fetal thymus 
Five IFN-γ inducible genes (STAT1, IFI16, CXCL10, CXCL16, and CXCR6) were analyzed using RT-








Figure 18.  Attenuated innate response in PI fetal thymus at day 190 of gestation after maternal 
infection.  The red arrows indicate genes that were decreased at day 190 of gestation in the PI fetal 







the innate immune response and production of IFN-γ is the link between the innate and adaptive 
immune systems.  The innate immune response eventually leads to activation and production of IFN-γ, 
this in turn then leads to activation of the adaptive immune response.  STAT1 is phosphorylated and 
translocates to the nucleus where it binds to gamma-activated sequence (GAS) to stimulate 
transcription and induce IFN signal transduction pathways (Decker et al., 1997).  In the fetal thymus, 
there was no change in STAT1 gene expression in any treatment group at any day.  However, STAT1 in 
BVDV fetal spleen and blood was previously shown to be increased during gestation at day 97 in PIs, 
followed with a decrease at day 192 (Smirnova et al., 2014).   These data and another experiment have 
shown a pronounced IFN response to the virus in blood and the spleen in acutely infected animals and 
to a lesser degree PI animals compared to controls (Shoemaker et al., 2009).  Fetal liver and spleen have 
also shown increases in IFN-γ, which may serve as possible sources for secreted IFN-γ (Smirnova et al., 
2014).  Other Flaviviruses such as dengue, yellow fever, and West Nile virus have been reported to 
inhibit the JAK/STAT signaling pathway by decreasing STAT1 phosphorylation using IFN antagonists 
(Randall et al., 2008, Cumberworth et al., 2017).  It has previously been shown that IFN antagonistic 
proteins have also contributed to “immunotolerance” of BVDV (Peterhans et al., 2010).  IFI16 is an IFN-γ 
inducible gene that is able to detect foreign DNA and RNA virus in the cytoplasm and nucleus triggering 
antiviral cytokines to DNA and RNA viruses (Thompson et al., 2014, Diner et al., 2015).  IFI16 along with 
apoptosis-associated speck-like protein (ASC) and caspase-1 form a protein complex called an 
inflammasome that is able to detect pathogenic microorganisms and activate various proinflammatory 
cytokines (Latz et al., 2013, Diner et al., 2015).   
Three different IFN-γ inducible chemokines were analyzed.  CXCL10 is able to stimulate  
monocyte, NK, and T cell migration as well as having a role in the antiviral response to viruses which 






Figure 19.  IFN induced chemokines suggests a decrease in T cell migration to the thymus in fetal thymuses after maternal infection at day 190 of 





APCS and functions as a chemoattractant for T cells in addition to being an adhesion molecule with 
CXCR6 being its specific receptor (Abel et al., 2004, Hara et al., 2006).   
IFN-γ inducible genes IFI16, CXCL16, and CXCR6 were significantly decreased in thymuses of PI 
fetuses at day 190 of gestation (Figure 19).  These data suggest that the adaptive immune response of 
the thymus is not functional, which contributes to the unleashed replication of the virus in host cells.  
IFN-γ inducible genes are suppressed in day 190 which may contribute to the virus’s ability to evade the 
host antiviral mechanisms and result in “immunotolerance” to the persisting virus.  These data coincide 
with previous studies showing that these genes were decreased in the fetal spleen at day 190 of 
gestation.  This may indicate a persistence of the BVDV mRNA in the blood (Figure 1).    
Decreased expression of genes along the MHC class I Pathway in response to fetal persistent infection in 
the thymus 
The MHC class I pathway is an important aspect of the adaptive immune response, especially 
during pregnancy.  IFN-γ and TNF-α play roles in upregulating MHC class I antigen processing and 
presentation along with TNFα.  IFN-γ is important for defense against intracellular pathogens.  IFN-γ is 
produced through IRF or NF-kB pathways in the innate immune system, with the majority of its 
production being through CD4+ and CD8+ T cell subsets (Ye et al., 1995).  Six genes (IFN-γ, LMP2, TAP1, 
β2M, CD8a, and CD8b) associated with the adaptive immune response were analyzed using real-time 
PCR within the MHC class II pathway at days 89, 97, 190, and 245 of gestation.  There was no change in 
expression of these genes between any of the treatment groups at any day of gestation.  However, this 
contradicts another study in which steers that had the mucosal disease, a mutation of ncpBVDV and 
concurrent infection with cpBVDV, of BVDV reported increased IFN-γ in the blood (Charleston et al., 
2002).  This difference may be due to the differences between blood and thymus or the increased 









Figure 20.  Decreased antigen presentation and cell mediated response at day 190 of gestation in PI fetal 
thymuses in the MHC I pathway.  The red arrows indicates genes that were decreased in day 190 of 







the immune system may be pushed into survival mode.  LMP2, TAP1, and β2M gene expression was 
increased in TI fetal thymuses at day 190 of gestation compared to control and PI thymuses.  The CD8 
and CD8b gene expression in TI fetuses were significantly higher in PI, but not compared to the controls 
at day 190 of gestation.  
The immunoproteasome is made up of LMP2, 7, and 10 (MECL-1) and as a whole it allows for 
BVDV endogenous antigens to be broken down into smaller peptides through proteolysis.  In this study 
LMP2 mRNA gene expression in PI thymuses was increased at day 97, but then decreased at both day 
190 and 245 of gestation.  This suggests that a normal immune response occurs early in the progression 
and detection of viral infection, but later, normal function is inhibited by the virus’s ability to manipulate 
host gene regulation pathways (Harwig et al., 2017).  This same increase of LMP2 mRNA at day 97 of 
gestation has also been reported in splenic tissue (Hansen et al., 2015).  Since IFN-γ is not increased, the 
initial LMP2 mRNA increase may be due to TNFα, but TNFα was not analyzed here.   
After antigenic peptide is broken down by the immunoproteasome, TAP (1 or 2) transports 
these peptides into the endoplasmic reticulum (ER) where they can bind to MHC class I molecules prior 
to being presented on the cell membrane.  TAP1 mRNA gene expression was increased in PI thymuses at 
day 97 and then dropped at day 190 and had a decreasing mRNA trend at day 245 of gestation.   This 
same increase of TAP1 mRNA at day 97 of gestation has also been reported in splenic tissue (Hansen et 
al., 2015).  These changes may indicate that while BVDV antigen can be transported normally, at first, it 
like the other aspects of the MHC class I pathway change in response to the virus intracellularly.   
Further downstream in the MHC class I pathway β2M protein assembles with the MHC I 
molecule in the ER to form a stable MHC I complex. β2M mRNA in PI thymuses was decreased at day 
190 and 245 of gestation.  In a previous study, β2M in PI fetal spleens at day 97 was found to be 
increased (Hansen et al., 2015).  When β2M is not present, MHC remains in the ER and the MHC I 
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complex is not expressed on the cell surface (Benedictus et al., 2015).  The thymus plays a major role in 
the T cell development, thus the adaptive immune response may be lagging behind accounting for the 
discrepancies between the spleen and thymus data.  These data in this section are summarized in Figure 
20.  
After the MHC I complex is presented on the surface of antigen presenting cells, the T cell co-
receptor, CD8, on cytotoxic T cells binds and the cytotoxic cell becomes an effector cell that can target 
cells infected with the same pathogen (Alberts et al., 2002a).  Cytotoxic T cells can release perforin, a 
protein that creates channels in the plasma membrane which causes infected cells to undergo 
apoptosis.  CD8a and CD8b mRNA in PI thymuses were decreased at day 190 and 245 of gestation.  
However, BVDV can induce the CD8+ T cell subpopulation in BVDV infected cattle, four to twenty-four 
months old, using flow cytometry (Rhodes et al., 1999).  CD8+ T cell induction was seen in naïve calves in 
which the adaptive immune system is fully developed and not in the development stages as was 
evaluated in this study.  
Downregulation of genes along the MHC class II pathway in response to fetal persistent infection in the 
thymus 
The MHC class II pathway is another important aspect of the adaptive immune response.  CD4+ 
T cells recognize processed antigenic peptides that are on the surface of antigen presenting cells (APCs) 
using this pathway; it uses endosomes or lysosomes to process the antigenic proteins and make them 
into small peptides.   In the case of BVDV, when CD4+ T cells decreased, there was an increased period 
of virus shedding (Chase et al., 2004).  
Three genes (CIITA, GILT, and CD4) were analyzed using RT-qPCR within the MHC class II 
pathway at days 89, 97, 190, and 245 of gestation.  CIITA is an IFN-γ stimulated gene, but it also serves a 
role as the major histocompatibility class II transactivator that allows for activation of MHC class II 
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expression (Xu et al., 2004, Shi et al., 2018).  CIITA and CD4 mRNA in the TI thymuses were not different 
compared to control thymuses.  However, these genes were decreased in the PI thymuses compared to 
control and TI fetal thymuses.  In addition to this, there was an increase of CIITA mRNA in PI fetal 
thymuses at day 97 followed by a decrease at days 190 and 245 of gestation.  Human cytomegalovirus 
(HCMV) and Epstein-Barr viruses can cause life-long infection in normal hosts and are able to block 
expression of MHC class II by inhibiting transcription of CIITA (Lee et al., 2011).  With HCMV infection, 
like shown with BVDV, after infection a transient increase of CIITA is initially observed, followed by 
reduction in gene expression at a later time point (Lee et al., 2011).  These changes that occur keep MHC 
class II molecules within cells, decreasing their normal presence on the surface membrane, subsequently 
reducing APCs ability to present antigens to CD4+ T cells which may account for the changes in the 
various gene transcripts measured in this study.       
GILT (IFI30) is also induced by interferon gamma and is expressed constitutively in antigen 
presenting cells.  One of its main functions is proteolysis in endosomes to make peptides available for 
antigen processing (Phan et al., 2000).  The only difference with gene expression of GILT was an 
increased in the PI thymuses at day 97 of gestation.  GILT expression has been previously shown to be  
increased after bacterial infection or under inflammatory conditions (Maric et al., 2001, Lackman et al., 
2006).  Along with IFN-γ, GILT is also induced by NF-kB, IL-1b, and TNF (Lackman and Cresswell 2006, 
Hastings et al., 2011).  In these studies, GILT mRNA only increased when NF-kB increased, but there was 
no decreased of GILT when NF-kB was decreased, likely because GILT is a constitutively expressed by 
APCs and can be induced by other signals.   
CD4 is a co-receptor expressed on helper T cells and is needed to bind to class II MHC proteins.  
Helper T cells stimulate macrophages to destroy intracellular microorganisms and help B cells and 








Figure 21. Decreased antigen presentation and cell mediated response at day 190 of gestation in PI fetal 
thymuses in the MHC II pathway. The red arrows indicates genes that were decreased in day 190 of 






thymuses at day 190 and 245 of gestation.  There was no change with CD4 protein, which may indicate 
translational disruption.  Human immunodeficiency virus type 1 (HIV-1) is an RNA virus that is able to 
inhibit translation and this same mechanism may also be true for BVDV however, more studies would 
need to be done to demonstrate it (Bour et al., 1997).  CD4+ T cells were also decreased in HCMV and 
Epstein-Barr infections which may be due to their inability of APCs to present antigen on their cell 
surface, which has also been seen with BVDV.  These data can all be summarized in Figure 21.    
CD79b and CD46 in the thymus after BVDV maternal infection using RT-qPCR 
Two additional genes (CD79b and CD46) were analyzed using real-time PCR in fetal thymus at 
days 89, 97, 190, and 245 of gestation.  CD79b, a B cell receptor gene, in cooperation with CD79a, is an 
important activator of B cells through the interaction with CD4+ T cells.  After this interaction, B cells 
then have the capability to proliferate, secrete antibodies, cytokines, and chemokines, and initiate 
memory cell formation (Bishop et al., 2003).  Differences with CD79b gene expression are only seen at 
day 190 of gestation with PI thymuses being considerably lower than both the control and TI data.  B 
cells are dependent on T cell activation and CD4 expression was shown to be decreased on the same 
day, these results are expected (Parker 1993). 
 CD46 is the receptor that BVDV uses to enter the cell (Maurer et al., 2004, Krey et al., 2006).  
There are no differences in CD46 in any treatment group at any day of gestation.  While CD46 serves as 
the receptor for BVDV, its numbers are not changed by its presence and thus does not affect entry of 
BVDV into cells (Krey et al., 2006).         
Histology of control, TI, and PI fetal thymuses at day 89, 97, 190, and 245 of gestation 
The rudimentary thymus is first detected around day 27 of gestation in ruminants.  Colonization 
and lymphoid development occurs around day 42 of gestation.  The day 42 progenitor cells comes from 
the fetal liver, until the bone marrow develops and matures enough and around day 70 and is able to 
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take over as the primary source of thymocytes (Goddeeris and Morrison 1994).  During thymocyte 
development cells can express CD4 or CD8 molecules on their surface.  The CD8 molecules expressed 
consist of CD8a and CD8b heterodimers.  However, extrathymic lymphocytes only express CD8a 
homodimers (Kioussis et al., 2002).  The CD8+ T cells are able to recognize cytosolic processed antigenic 
peptides from the MHC class I pathway.   
There were no gross differences between control, TI, and PI fetal thymuses during in utero 
development at any day of gestation with H&E staining, but since the ncpBVDV was used in these 
studies, no lysis was expected.  However, differences in T cells are expected, but H&E staining does not 
differentiate T cells.  IRF7 and STAT1 are essential for the development of medullary thymic epithelial 
cells (mTECs) and maintenance of thymic architecture and because we see no decrease in any of these 
genes, it ties in with the fact that there is no gross histology changes seen with H&E (Otero et al., 2013).  
Extensive immunohistochemistry testing will need to be performed in order to evaluate changes in 
specific cell populations after maternal infection with BVDV.  In a previous study that analysed the 
spleen, there were no histopathological changes in the PI infected fetuses except for an increase in the 
number of megakaryocytes an early development of some periarteriolar lymphoid sheaths and as we 
saw in the thymus, the spleen also had normal development in TI infected fetuses (Shoemaker et al., 
2009).  BVDV antigen and ISG15 were both detected in macrophage-like cells in the spleen thus would 
be a proper follow-up experiment in the fetal thymus tissues (Shoemaker et al., 2009).  These same 
experiments also detected BVDV in Kupffer cells of the fetal liver as well as an increase in antigen 
presenting cells (Morarie-Kane et al., 2018). 
Thus far, experiments measuring BVDV have been performed in the spleen, liver and now the 
thymus.  The spleen and liver have indicated that an activated immune response occurs in these 
lymphoid tissues, however, in the thymus the innate and adaptive immune response appears to be 
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attenuated.  This is interesting because it may suggest that BVDV affects primary lymphoid organs first, 





















OVERALL SUMMARY AND FUTURE DIRECTIONS 
  These studies investigated numerous genes in the innate and adaptive immune systems.  The 
experimental model used for the scope of this work allowed for analysis of acute and chronic stages of 
PI.  The major finding that emerged from the examination of the innate immune system of the fetal 
thymus in PIs was that there was no increase in any gene tested of the innate immune response, with 
the exception of NF-kB in PI fetal thymus.  This may be an indication that “immunotolerance” reflects a 
lack of development of the immune system or the virus evading the immune system.  When the immune 
system is unable to immunologically recognize BVDV, this is referred to as “immunotolerance”. 
 Historically it was always portrayed that BVDV creates “immunotolerance” however, genes of 
adaptive immune system were actually downregulated, which indicates that the virus may be causing 
dysfunction of the adaptive immune response in the fetal thymus.  The decrease of genes in the 
adaptive immune system was an unexpected finding that could be directly caused by BVDV altering host 
cells.  “Immunotolerance” may be exacerbated because the day 190-245 fetal thymus is still in its 
development stages.    
  Innate genes from the TI fetal thymus had a global increase in expression.  At 190 days of 
gestation, the TI fetal thymuses had a normal functioning and developed immune system and thus the 
increase in gene expression was expected.  This was also true for the IFN induced genes IFI16 and 
CXCL16, as well as genes in the adaptive pathway including LMP2, TAP1, β2M, and CIITA.  However, it is 
unclear if TI with BVDV during fetal development has detrimental postnatal epigenetics effects.  A 
postnatal study would clarify if there are any long lasting effects.      
 This study compared protein and RNA of IRF7, ISG15, and CD4.  The protein data of IRF7, CD4, 
and the free form of ISG15 did not reflect the mRNA data. It was very likely that any free ISG15 protein 
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was being consumed through formation of conjugated ISG15.  The ISG15 conjugated form protein 
mirrored that of RNA, in which conjugated ISG15 was significantly upregulated with BVDV TI.  Up to this 
point, there is not enough data to explain why IRF7 and CD4 western blot analyses were different from 
RT-PCR data.  There are many viruses that inhibit translation of the host cell, which is known as “shutoff” 
(Toribio et al., 2010, Li et al., 2015).  In response to viral infection, ISGs are supposed to block viral 
replication, but as shown, ISG15 protein is not increased in PIs, like it is in TIs, which may be contributing 
to host translational shutoff, but further studies are necessary to determine if this strategy applies to 
BVDV.  Also, there may be discrete cell-specific changes in protein that can be discernable through 
sensitive immunohistochemistry approaches and that won’t be detected by using western blot.  For 
example, in a previous study it was demonstrated that ISG15 protein did not change in fetal PI spleens 
based on western blot, but when tissue sections were examined by immunohistochemistry, there was 
very specific upregulation of ISG15 protein in macrophage-like cells from PI compared to control spleens 
(Shoemaker et al., 2009).  Western blot analyses of CD8, CD79b, and LMP2 protein was considered for 
the present studies however, either the antibodies of interested were not available in bovine or the 
antibody of interest in a different species had a low protein sequence homology to bovine.  For these 
reasons, analyses of the protein to the RNA tested was limited.  Thymus protein and RNA analyses was 
then followed up with histological interpretation of the tissue.   
BVDV has a tropism for thymus tissue and has been reported to cause thymic atrophy which 
include a reduction of the cortex:medulla ratio.  The studies that showed atrophy in the thymus used 3 
to 5 week old calves to evaluate the thymus after the acute or persistent infection (Romero-Palomo et 
al., 2015, Falkenberg et al., 2017).  However, thymus tissues collected in this study were all done in utero 
which may help pinpoint the time of thymic change.  As discussed chapter 2, histopathology was 
evaluated at day 89, 97, 190, and 245 of gestation and at each day there were no developmental 
differences seen between control, TI, or PI thymuses.  Normal development of the lymphoid follicles and 
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the cortex:medulla ratio was as it should be for each day of gestation.  The normal development of the 
thymus, may indicate that the thymic atrophy does not begin until after birth.  In addition to the 
infection, environmental stressors such as prolonged physical or emotional stress, can lead to thymic 
atrophy which is another reason for postnatal studies of BVDV to be performed (Gruver et al., 2008).  
Various stressors cause an increase production of cortisol, a stress hormone, which then leads to thymus 
involution as well as decreased thymopoiesis.   
There has been some question as to whether epigenetics mechanisms are altered by various 
pathogens, including BVDV.  DNA methylation is an important epigenetic mechanism that has roles in 
silencing gene transcription, protein expression, and regulating miRNAs.  A previous in vitro study 
showed decreased methylation levels of various promoters in MDBK cells after they were infected with 
BVDV (Fu et al., 2017).  One of these promoters was DNMT1, a DNA methyltransferase that helps 
maintain methylation, and by silencing it the BVDV NADL strain was able to be suppressed (Fu et al., 
2017).  Additional in vivo experiments with BVDV would need to be performed in the fetal thymus in 
order to ascertain if epigenetic changes seen in vitro occur in vivo.  These epigenetic changes may be the 
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